Local Anesthesia for Hip Fracture Surgery
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to compare two commonly used local/regional anesthesia techniques in adults patients undergoing hip fracture surgery. The main question\[s\] it aims to answer are: • the impact of both interventions on patient level of pain. • impact on postoperative analgesics administered Participants will be randomly assigned to one of two local/regional anesthesia techniques, either femoral nerve block (FNB) or suprainguinal fascia iliaca block (SiFi). Both techniques are the usual practice at the hospital, and we are NOT aiming to experiment on new anesthesia technique in this study.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Regional Anesthesia, Nerve Blocks, Neuraxial Anesthesia, Peripheral Nerve Blocks, Intravenous Regional Anesthesia, Spinal Anesthesia, Epidural Anesthesia for hip fracture surgery?
Research shows that regional anesthesia, including peripheral nerve blocks and spinal anesthesia, can reduce complications and improve patient satisfaction compared to general anesthesia. Additionally, peripheral nerve blocks are beneficial for pain management and may reduce the risk of confusion and heart issues after hip fracture surgery.12345
Is local anesthesia for hip fracture surgery safe?
Peripheral nerve blocks, a type of local anesthesia, are increasingly used for hip fractures and are generally considered safe, though there are some risks like overdosage and nerve damage. Studies suggest that regional anesthesia, including nerve blocks, may have fewer adverse events compared to general anesthesia, and can even reduce mortality in high-risk patients.678910
How is regional anesthesia different from other treatments for hip fracture surgery?
Regional anesthesia, like nerve blocks, is unique because it targets specific nerves to numb the area around the hip fracture, potentially offering better pain control and fewer side effects than general anesthesia. It can be particularly beneficial for patients with other health issues, as it may provide stable conditions during surgery and effective pain relief afterward without the complications associated with general anesthesia.311121314
Eligibility Criteria
This trial is for adults over 18 who are having hip fracture surgery at the University of Alberta Hospital and can receive multimodal analgesia with a nerve block. It's not suitable for those who have conditions that make nerve blocks unsafe or those who don't consent to this type of anesthesia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Anesthesia
Participants receive either femoral nerve block or suprainguinal fascia iliaca block preoperatively
Postoperative Monitoring
Participants are monitored for pain scores and opioid utilization post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Regional Anesthesia
Regional Anesthesia is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Orthopedic procedures
- Gynecological procedures
- Gastrointestinal procedures
- Chronic pain management
- Ankle fracture pain control
- Childbirth
- Prostate surgery
- Knee surgery
- Shoulder surgery
- Chronic pain management
- Orthopedic procedures
- Gynecological procedures
- Gastrointestinal procedures
- Chronic pain management
- Orthopedic procedures
- Gynecological procedures
- Gastrointestinal procedures
- Chronic pain management
- Orthopedic procedures
- Gynecological procedures
- Gastrointestinal procedures
- Chronic pain management
- Orthopedic procedures
- Gynecological procedures
- Gastrointestinal procedures
- Chronic pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor